Research Summaries

The FDA has approved new options for major depressive disorder, schizophrenia, and metastatic non-small cell lung cancer, that clinicians should be aware of.

The FDA has decided to strengthen existing cardiovascular warnings on the labels of prescription non-aspirin nonsteroidal anti-inflammatory drugs.

New research examined the role of lung function early in life in the risk of developing chronic obstructive pulmonary disease later in life.

A recent study tested the potential of antimicrobial compounds found in peppermint and cinnamon to treat wound-infecting biofilms.

Researchers examined the role that wheat, gluten, and fermentable oliogo-di-monosaccharides and polyols sensitivity may play in causing irritable bowel syndrome symptoms.

The FDA has approved new options for the treatment of heart failure and cystic fibrosis, and issued a warning on unapproved prescription ear drops.

Researchers evaluated the impact of bariatric surgery and lifestyle interventions on remission rates in patients with type 2 diabetes mellitus.

A recent report discusses the factors responsible for underestimated rates of hepatitis C virus infection in the United States.

Recent research examined the effectiveness of current guidelines for the treatment and diagnosis of chronic obstructive pulmonary disease, and the risks of misdiagnosis.

Recent research examined the effects of menopause on the risk of developing coronary heart disease.